Kadimastem (Israel) Today
| KDST Stock | ILA 496.00 11.60 2.39% |
Performance0 of 100
| Odds Of DistressLess than 43
|
Kadimastem is trading at 496.00 as of the 19th of April 2024, a 2.39 percent increase since the beginning of the trading day. The stock's open price was 484.4. Kadimastem has about a 43 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Kadimastem has reported 10 for 1 split on 31st of March 2024. Equity ratings for Kadimastem are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of May 2022 and ending today, the 19th of April 2024. Click here to learn more.
Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. The company was founded in 2008 and is based in Ness Ziona, Israel. KADIMASTEM operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. The company has 35.76 M outstanding shares. More on Kadimastem
Moving against Kadimastem Stock
| 0.53 | DSCT | Israel Discount Bank | PairCorr |
| 0.46 | LUMI | Bank Leumi Le | PairCorr |
| 0.44 | FIBIH | FIBI Holdings | PairCorr |
Kadimastem Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Kadimastem's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Kadimastem or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Ram Epstein |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Kadimastem (KDST) is traded on Tel Aviv Stock Exchange in Israel and employs 23 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 30.32 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kadimastem's market, we take the total number of its shares issued and multiply it by Kadimastem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Kadimastem operates under Biotechnology sector and is part of Health Care industry. The entity has 35.76 M outstanding shares.
Kadimastem has accumulated about 5.43 M in cash with (21.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Check Kadimastem Probability Of Bankruptcy
Ownership AllocationKadimastem holds a total of 35.76 Million outstanding shares. Kadimastem holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Kadimastem Ownership Details
Kadimastem Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Kadimastem market risk premium is the additional return an investor will receive from holding Kadimastem long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Kadimastem. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Kadimastem's alpha and beta are two of the key measurements used to evaluate Kadimastem's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.06 | |||
| Standard Deviation | 4.51 | |||
| Variance | 20.35 | |||
| Risk Adjusted Performance | (0.02) |
Kadimastem Stock Against Markets
Picking the right benchmark for Kadimastem stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Kadimastem stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Kadimastem is critical whether you are bullish or bearish towards Kadimastem at a given time. Please also check how Kadimastem's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Kadimastem without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Kadimastem Corporate Directors
Kadimastem corporate directors refer to members of a Kadimastem board of directors. The board of directors generally takes responsibility for the Kadimastem's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Kadimastem's board members must vote for the resolution. The Kadimastem board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Keren Tzlill | External Director | Profile | |
| David Sultan | Independent Director | Profile | |
| Michel Revel | Chief Scientific Officer-Services Provider, Director | Profile | |
| Joseph Eldor | Director | Profile |
How to buy Kadimastem Stock?
Before investing in Kadimastem, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Kadimastem. To buy Kadimastem stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Kadimastem. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Kadimastem stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Kadimastem stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Kadimastem stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Kadimastem, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Kadimastem?
The danger of trading Kadimastem is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Kadimastem is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Kadimastem. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Kadimastem is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kadimastem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Kadimastem Stock analysis
When running Kadimastem's price analysis, check to measure Kadimastem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kadimastem is operating at the current time. Most of Kadimastem's value examination focuses on studying past and present price action to predict the probability of Kadimastem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kadimastem's price. Additionally, you may evaluate how the addition of Kadimastem to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |